Reappraisal of an ALS trial: unaccounted procedural risk
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- Amyotrophic Lateral Sclerosis (MeSH)
- Double-Blind Method (MeSH)
- Edaravone (MeSH)
- Humans (MeSH)
- Neurology & Neurosurgery (Science Metrix)
published in
- Lancet Neurology Journal